These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2326549)

  • 1. Ketoconazole-induced hepatic lysosomal phospholipidosis: the effect of concurrent barbiturate treatment.
    Pakuts AP; Parks RJ; Paul CJ; Bujaki SJ; Mueller RW
    Res Commun Chem Pathol Pharmacol; 1990 Jan; 67(1):55-62. PubMed ID: 2326549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketoconazole-induced hepatic phospholipidosis in the mouse and its association with de-N-acetyl ketoconazole.
    Whitehouse LW; Menzies A; Mueller R; Pontefract R
    Toxicology; 1994; 94(1-3):81-95. PubMed ID: 7801332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemistry of LAMP-2 and adipophilin for phospholipidosis in liver and kidney in ketoconazole-treated mice.
    Asaoka Y; Togashi Y; Imura N; Sai T; Miyoshi T; Miyamoto Y
    Exp Toxicol Pathol; 2013 Sep; 65(6):817-23. PubMed ID: 23276623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic effects of ketoconazole in the male Swiss Webster mouse: temporal changes in drug metabolic parameters.
    Whitehouse LW; Pakuts AP; Paul CJ; Mueller RW; Thomas BH
    Can J Physiol Pharmacol; 1990 Aug; 68(8):1136-42. PubMed ID: 2390740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent subacute exposure to arsenic through drinking water and malathion via diet in male rats: effects on hepatic drug-metabolizing enzymes.
    Naraharisetti SB; Aggarwal M; Sarkar SN; Malik JK
    Arch Toxicol; 2008 Aug; 82(8):543-51. PubMed ID: 18528686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of dietary thiamin on phenobarbital induction of rat hepatic enzymes responsible for metabolizing drugs and carcinogens.
    Wade AE; Evans JS; Holmes D; Baker MT
    Drug Nutr Interact; 1983; 2(2):117-30. PubMed ID: 6432511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic microsomal enzyme induction, beta-oxidation, and cell proliferation following administration of clofibrate, gemfibrozil, or bezafibrate in the CD rat.
    Amacher DE; Beck R; Schomaker SJ; Kenny CV
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):143-50. PubMed ID: 9007043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic fate of the new anti-ulcer drug enprostil in animals. 4th communication: effect on hepatic drug metabolizing enzyme system in rats.
    Yamada Y; Nakahara M; Kohno M; Otsuka M; Takaiti O
    Arzneimittelforschung; 1989 Mar; 39(3):356-60. PubMed ID: 2502989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dimemorfan N-demethylation by mouse liver microsomal cytochrome P450 enzymes.
    Chou YC; Ueng YF; Chou CY; Tien JH
    Life Sci; 2005 Jul; 77(7):735-45. PubMed ID: 15936348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of ketoconazole on hepatic oxidative drug metabolism in the rat in vivo and in vitro.
    Meredith CG; Maldonado AL; Speeg KV
    Drug Metab Dispos; 1985; 13(2):156-62. PubMed ID: 2859162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of tumor promoting contraceptive steroids on growth and drug metabolizing enzymes in rat liver.
    Ochs H; Düsterberg B; Günzel P; Schulte-Hermann R
    Cancer Res; 1986 Mar; 46(3):1224-32. PubMed ID: 3943094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The acute and subchronic effects of ketoconazole on hepatic microsomal monooxygenases in the rat.
    Thomson RG; Rawlins MD; James OF; Wood P; Williams FM
    Biochem Pharmacol; 1988 Oct; 37(20):3975-80. PubMed ID: 3190741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of dietary carbohydrates (alpha-saccharides) on hepatic drug metabolism in male rats.
    Sonawane BR; Coates PM; Yaffe SJ; Koldovsky O
    Drug Nutr Interact; 1983; 2(1):7-16. PubMed ID: 6678749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of acute and repeated chlordimeform treatment on rat hepatic microsomal drug metabolizing enzymes.
    Budris DM; Yim GK; Schnell RC
    J Environ Pathol Toxicol Oncol; 1984 Jul; 5(4-5):175-82. PubMed ID: 6440975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of cyclosporine A on renal and hepatic microsomal mixed function oxidase systems in rats.
    Machková Z; Mostecká H; Seifert J; Masek K
    Methods Find Exp Clin Pharmacol; 1990 May; 12(4):239-44. PubMed ID: 2374470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of four hypolipidaemic agents on the activity of drug-metabolizing enzymes in rat liver microsomes.
    Fournel S; Magdalou J; Batt AM; Siest G
    Int J Clin Pharmacol Res; 1983; 3(6):431-6. PubMed ID: 6432712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Midazolam and triazolam biotransformation in mouse and human liver microsomes: relative contribution of CYP3A and CYP2C isoforms.
    Perloff MD; von Moltke LL; Court MH; Kotegawa T; Shader RI; Greenblatt DJ
    J Pharmacol Exp Ther; 2000 Feb; 292(2):618-28. PubMed ID: 10640299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic drug metabolism and protein malnutrition.
    Rumack BH; Holtzman J; Chase HP
    J Pharmacol Exp Ther; 1973 Sep; 186(3):441-6. PubMed ID: 4199525
    [No Abstract]   [Full Text] [Related]  

  • 20. Regenerative changes in hepatic morphology and enhanced expression of CYP2B10 and CYP3A during daily administration of cocaine.
    Pellinen P; Stenbäck F; Kojo A; Honkakoski P; Gelboin HV; Pasanen M
    Hepatology; 1996 Mar; 23(3):515-23. PubMed ID: 8617431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.